Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
China Isotope & Radiation Corp. ( (HK:1763) ) just unveiled an announcement.
China Isotope & Radiation Corporation announced the completion of the transfer registration for a gratuitous transfer of shares by its controlling shareholder, China Baoyuan Investment Co., Ltd., to China National Nuclear Corporation. This transfer involves 108,085,353 domestic shares, representing approximately 33.79% of the company’s total issued share capital. Despite the transfer, China Baoyuan remains the ultimate controlling shareholder, indicating a strategic alignment with China National Nuclear Corporation, potentially strengthening the company’s position in the nuclear technology sector.
More about China Isotope & Radiation Corp.
China Isotope & Radiation Corporation operates in the nuclear technology industry, focusing on the production and distribution of isotopes and radiation-related products. The company is a key player in the Chinese market, providing essential services and products for medical, industrial, and scientific applications.
Average Trading Volume: 523,228
Technical Sentiment Signal: Buy
Current Market Cap: HK$5.7B
For a thorough assessment of 1763 stock, go to TipRanks’ Stock Analysis page.